Search Results for: represent unfair

An investigation for investors in NYSE:FMD shares was announced concerning whether the takeover of The First Marblehead Corporation for $5.05 per share is unfair to NYSE:FMD stockholders. Investors who purchased shares of The First Marblehead Corporation (NYSE:FMD) and currently hold any of those NYSE:FMD shares have certain options and should contact the Shareholders Foundation at […]

An investigation for investors in NASDAQ:SQI shares was announced concerning whether the takeover of SciQuest, Inc. by affiliates of Accel-KKR for $17.75 per share is unfair to NASDAQ:SQI stockholders. Investors who purchased shares of SciQuest, Inc. (NASDAQ:SQI) and currently hold any of those NASDAQ:SQI shares have certain options and should contact the Shareholders Foundation at […]

An investigation for investors in NASDAQ:MHGC shares was announced concerning whether the takeover of Morgans Hotel Group Co. by SBE for $2.25 per share. Investors who purchased shares of Morgans Hotel Group Co. (NASDAQ:MHGC) and currently hold any of those NASDAQ:MHGC shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call […]

An investor in NYSE:STJ shares filed a lawsuit in effort to halt the proposed takeover of St. Jude Medical, Inc. by Abbott is unfair. Investors who purchased shares of St. Jude Medical, Inc. (NYSE:STJ) and currently hold any of those NYSE:STJ shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call […]

An investor in NASDAQ:AFOP shares filed a lawsuit in effort to halt the proposed takeover of Alliance Fiber Optic Products Inc. by for $18.50 per share. Investors who purchased shares of Alliance Fiber Optic Products Inc (NASDAQ:AFOP) and currently hold any of those NASDAQ:AFOP shares have certain options and should contact the Shareholders Foundation at […]

An investigation on behalf of investors, who currently hold shares of Examworks Group, Inc. (NYSE:EXAM), was announced concerning whether the takeover of Examworks Group, Inc. for $35.05 per share is unfair to NYSE:EXAM stockholders. Investors who purchased shares of Examworks Group, Inc. (NYSE:EXAM) and currently hold any of those NYSE:EXAM shares have certain options and […]